Skip to Main Content
Skip Nav Destination

A Universal Transplant Strategy for Blood Cancer?

June 7, 2024

Abstract: A systematic exploration of epitope-edited CD45 variants enabled researchers to create “shielded” hematopoietic stem cells that resist CD45-targeted therapy while maintaining full functionality. This approach, demonstrated in mouse models, could allow for precise eradication of most blood cancers without the toxicity of conventional bone-marrow transplants.

You do not currently have access to this content.
Don't already have an account? Register
Close Modal

or Create an Account

Close Modal
Close Modal